Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Net Cash Flow (2023 - 2026)

Updated

Genmab A (GMAB) reported Net Cash Flow of -$22 million for the quarter ended Jun 30, 2026.

Analysis

Genmab A (GMAB) Net Cash Flow (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Genmab A's Net Cash Flow came in at $487 million; for the year ended Dec 31, 2025, it came in at $332 million.

  • By year, Net Cash Flow came in at -$887 million in the year ended Dec 31, 2024 and $797 million in the year ended Dec 31, 2023.
  • Five-year quarterly Net Cash Flow spans a low of -$3.49 billion in the quarter ended Dec 31, 2023 and a high of $2.61 billion in the quarter ended Mar 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -4.12 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -3.52 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 4.21 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 2.81 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.26 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 843.00 Mn
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 360.00 Mn
Jun 30, 2026 -22.00 Mn
Mar 31, 2026 -183.00 Mn
Sep 30, 2025 461.00 Mn
Mar 31, 2025 231.00 Mn
Sep 30, 2024 279.00 Mn
Mar 31, 2024 -76.00 Mn
Dec 31, 2023 -3.49 Bn
Mar 31, 2023 2.61 Bn
API Access

Genmab A Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=GMAB&period=max&api_key=YOUR_API_KEY